Market
Scenario:
A glucose tolerance test measures how well a body’s cells
is capable to engross glucose, or sugar, after a patient consume a given amount
of sugar. Doctors and specialists use fasting blood sugar levels and
haemoglobin A1c values to identify type 1 and type 2 diabetes, and pre-diabetes
whereas a glucose tolerance test can also be used. Doctors primarily use a
glucose tolerance test to diagnose gestational diabetes in patients. Factors
such as Increasing prevalence and incidence of diabetes mellitus (DM), Rise in
technological innovations, Research funding in diabetes diagnosis and
treatment, and rising awareness and screening for Diabetes Mellitus are some of
the major factors driving the growth of the market. Further Stringent
reimbursement and insurance policies in developing nations, High cost
associated with diagnosis and treatment of diabetes can hamper the market
growth in coming future.
The global Glucose Tolerance Test market is expected to
grow at a CAGR of 10.4% during the forecast period 2017-2023.
Segmentation:
The global Glucose Tolerance Test market is
segmented on the basis of products, indications, end user.
On the basis of the products, it is further segmented
into intramedullary Blood glucose testing kit (Lancet, Meters, Test strips and
others), Smart sensors and other .
On the basis of the indication, the market is segmented
into Diabetes, Gestational diabetes, Insulin resistance, Reactive
hypoglycemia.
On the basis of the end user, the market is segmented
into Diagnostic Clinics, Hospitals, Home, and others.
Intended
Audience:
·
Pharmaceutical Companies
·
Medical Devices Manufacturer
·
Research and Development (R&D) Companies
·
Market Research and Consulting Service
Providers
·
Potential Investors
Regional
Analysis:
The Americas dominate the diabetes monitors market owing
to the presence of patient population, a well-developed technology, high
healthcare expenditure, and the presence of the leading players. Due to high
prevalence of the condition, companies, private organization, and government
associations actively participates to improve diabetes care. For instance, The
Merck Foundation provided funding of USD 10,000,000 for the projects designed
to improve access to diabetes care and to reduce health disparities for
vulnerable populations with type 2 diabetes in the United States.
According to the German maternity guidelines, every
pregnant women can undergo glucose-challenge test for early diagnosis of
Gestational diabetes mellitus (GDM). The charges for the test are completely
covered by women’s health insurance.
Key
Players:
Some of the key players in this market are Panasonic,
Dexcom, Inc, Abbott Laboratories, F. Hoffman-La Roche Ltd, LifeScan, Inc
Sanofi, Medtronic Plc and others
Get Your
Customized Report @ https://www.marketresearchfuture.com/reports/glucose-tolerance-test-market-4921
Table
of Content:
1 REPORT PROLOGUE
2 MARKET
INTRODUCTION
2.1 Introduction 16
2.2 Scope Of Study 16
2.3 Research Objective 16
2.4 Assumptions & Limitations 17
2.4.1 Assumptions 17
2.4.2 Limitations 17
3 RESEARCH
METHODOLOGY
3.1 Research Process 18
3.2 Primary Research 19
3.3 Secondary Research 19
3.4 Market Size Estimation 19
3.5 Forecast Model 20
TOC
Continued…!
About
US:
Market Research Future (MRFR), enable customers to
unravel the complexity of various industries through Cooked Research Report
(CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R),
Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Contact
Us:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune - 411028
Maharashtra, India
Phone:
+1
646 845 9312
No comments:
Post a Comment